Article
DDX3X mediates EGFR-TKI resistance through VEGFR signaling
2021-12-01
Abstract excerpt
Although epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are remarkably effective against non-small-cell lung cancer (NSCLC) with EGFR -activating mutations, lung cancer cells acquire resistance to EGFR-TKIs without exception. Several mechanisms of EGFR-TKI resistance have been reported, but there are many aspects that remain to be clarified. We previously identified DDX3X as an immunogen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a7318e6-557a-5531-aeca-5f05189ca1fa
- DOI
- 10.21203/rs.3.rs-1073662/v1
